Thank you, Didier. We reported a net loss of $4.2 million or $0.17 per diluted share and net revenues of $8.8 million for the first quarter of fiscal 2022, compared to a net loss of $6.1 million or $0.26 per diluted share and net revenues of $6.6 million for the first quarter of fiscal 2021 and a net loss of $5 million or $0.21 per diluted share and net revenues of $7.7 million for the fourth quarter of fiscal 2021. Gross margin was 54.4% compared to 46.1% in the prior year period and 50.2% in the preceding fourth quarter. Improvement in gross margin was primarily due to changes in product mix sold in the quarter, which reflects an increase in higher margin SigmaQuad sales as compared to the prior periods. Total operating expenses in the first quarter of fiscal 2022, were $9.1 million, compared to $8.7 million in the first quarter of fiscal 2021 and $9.1 million in the prior quarter. Research and development expenses were $6.1 million, compared to $5.8 million in the prior year period and $6.1 million in the prior quarter. Selling, general and administrative expenses were $3 million in the quarter ended June 30, 2021, compared to $2.9 million in the prior year quarter and $3 million in the previous quarter. First quarter fiscal 2022 operating loss was $4.4 million, compared to $5.7 million in the prior year period and $5.3 million in the prior quarter. First quarter fiscal 2022 net loss was $4.2 million, compared to a net loss of $6.1 million in the first quarter of fiscal 2021 and $5 million in the fourth quarter of fiscal 2021. First quarter fiscal 2022 net loss included interest and other expense of $20,000 and a tax benefit of $172,000, compared to interest and other income of $106,000 and a tax provision of $487,000 in the prior year, primarily resulting from the settlement of a tax audit in Israel fiscal years 2017 through 2019. In the preceding fourth quarter, net loss included interest and other expense of $21,000 and a tax benefit of $304,000. Total first quarter pre-tax stock-based compensation expense was $823,000, compared to $755,000 in the comparable quarter a year ago and $753,000 in the prior quarter. At June 30, 2021, the company had $51.5 million in cash, cash equivalents and short-term investments and $4.3 million in long-term investments, compared to $54 million in cash, cash equivalents and short-term investments and $5.8 million in long-term investments at March 31, 2021. Working capital was $54.8 million, as of June 30, 2021 versus $56 million at March 31, 2021 with no debt. As of June 30, 2021 stockholders' equity was $73 million, compared to $75.6 million as of the fiscal year ended March 31, 2021. For the upcoming second quarter fiscal year 2022, our current expectations are net revenues in the range of $6.9 million to $7.9 million with gross margin of approximately 51% to 53%. Supply chain shortages and the impact of rising COVID infections in Taiwan that have recently impacted the operation of our manufacturing partners are expected to impact our fulfillment of sales in the near-term and possibly for the remainder of calendar year. Operator at this point, we'll open the call to Q&A.